// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Community respiratory diagnosis: It’s more than just spirometry

Ross Beech - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Usefulness of physiological tests of small airways function in diagnosing asthma: a systematic review

Mohammed Almeshari - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

The potential role of pre-operative cardiopulmonary exercise testing in endovascular aortic repair

Edward Parkes - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Incidence of clinically significant ECG abnormalities in healthy volunteers participating in cardio-pulmonary exercise research

Joanna Shakespeare - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

Peak heart rate to assess maximal exercise in arm ergometry

Joanna Shakespeare - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparative assessment of the incremental shuttle walk and incremental cycle ergometry tests in patients with idiopathic pulmonary fibrosis

Elizabeth Dobson - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Clinical presentation in patients with isolated bilateral Diaphragmatic Palsy.and MEP/MIP ratio as an aid to diagnosis

Milind Sovani - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Hypoxic Challenge Testing in Infants; who is recommended in-flight oxygen?

Emma Fettes - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Correlation of Hyperpolarised Xenon-129 Magnetic Resonance Imaging (129Xe-MRI of the Lung with Multi-Breath Washout (MBW in Children with Severe Asthma

Shahideh Safavi - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Interpretation of multiple breath washout (MBW measurements of lung function using mathematical modelling and hyperpolarised 3He gas MRI

Carl Whitfield - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

A pilot study of a novel ELISA test using synthetic mycolic acid antigens for serodiagnosis of nontuberculous mycobacterial infections

Julia Bashford - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Late Breaking Abstract - Experimental Respiratory Syncytial Virus infection in adults 60-75 years

Alex Mann - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma

Maisha Jabeen - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Clinical phenotypes of exacerbation are associated with differences in microbial composition and diversity in COPD

Holly Rachael Keir - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

A high-risk airway mycobiome characterises frequent COPD exacerbators

Pei Yee Tiew - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Co-occurrence analysis relates a macrolide resistome to the pulmonary microbiome in chronic respiratory disease

Jayanth Kumar Narayana - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

N/A

“Integrative microbiomics” reveals a disrupted interactome in bronchiectasis exacerbations

Jayanth Kumar Narayana - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Relationship Between Symptoms, Exacerbations And Treatment Response in Bronchiectasis

Yonghua Gao - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Efficacy of inhaled dry powder tobramycin (TOBI Podhaler in P. aeruginosa infected patients with bronchiectasis - iBEST study

Michael Loebinger - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

TOBI Podhaler

Late Breaking Abstract - Efficacy of DPP1 inhibition with brensocatib in subgroups of patients with bronchiectasis- the WILLOW study

James D. Chalmers - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Elaszym

Copyright © 2026. QuantiNova All rights reserved